Federal Register / Vol. 69, No. 244 / Tuesday, December 21, 2004 / Notices 76479

DEPARTMENT OF JUSTICE

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of 1993—National Electronic 

Distributors Association 

Notice is hereby given that, on 

October 8, 2004, pursuant to section 6(a) 

of the National Cooperative Research 

and Production Act of 1993, 15 U.S.C. 

4301 et seq. (‘‘the Act’’), National 

Electronic Distributors Association 

(‘‘NEDA’’) has filed written notifications 

simultaneously with the Attorney 

General and the Federal Trade 

Commission disclosing (1) the name and 

principal place of business of the 

standards development organization 

and (2) the nature and scope of its 

standards development activities. The 

notifications were filed for the purpose 

of invoking the Act’s provisions limiting 

the recovery of antitrust plaintiffs to 

actual damages under specified 

circumstances. 

Pursuant to section 6(b) of the Act, the 

name and principal place of business of 

the standards development organization 

is: National Electronic Distributors 

Association, Alpharetta, GA. The nature 

and scope of NEDA’s standards 

development activities are: establishing 

and publishing voluntary standards 

related to packaging, handling, labeling, 

shipping and tracking products and 

operational agreements between 

business partners in the electronic 

component supply chain.

Dorothy B. Fountain, 

Deputy Director of Operations, Antitrust 

Division.

[FR Doc. 04–27873 Filed 12–20–04; 8:45 am] 

BILLING CODE 4410–11–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration 

Agency Information Collection 

Activities: Proposed Collection; 

Comments Requested

ACTION: 60-Day notice of information 

collection under review: ARCOS 

transaction reporting—DEA Form 333. 

The Department of Justice (DOJ), Drug 

Enforcement Administration (DEA), has 

submitted the following information 

collection request to the Office of 

Management and Budget (OMB) for 

review and approval in accordance with 

the Paperwork Reduction Act of 1995. 

The proposed information collection is 

published to obtain comments from the 

public and affected agencies. Comments 

are encouraged and will be accepted for 

‘‘sixty days’’ until February 22, 2005. 

This process is conducted in accordance 

with 5 CFR 1320.10. 

If you have comments, especially on 

the estimated public burden or 

associated response time, suggestions, 

or need a copy of the proposed 

information collection instrument with 

instructions or additional information, 

please contact Patricia M. Good, Chief, 

Liaison and Policy Section, Office of 

Diversion Control, Drug Enforcement 

Administration, Washington, DC 20537. 

Written comments and suggestions 

from the public and affected agencies 

concerning the proposed collection of 

information are encouraged. Your 

comments should address one or more 

of the following four points:

—Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

—Evaluate the accuracy of the agencies 

estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

—Enhance the quality, utility, and 

clarity of the information to be 

collected; and 

—Minimize the burden of the collection 

of information on those who are to 

respond, including through the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms 

of information technology, e.g., 

permitting electronic submission of 

responses.

Overview of this information 

collection: 

(1) Type of Information Collection:

Extension of a currently approved 

collection.

(2) Title of the Form/Collection:

ARCOS Transaction Reporting—DEA 

Form 333. 

(3) Agency form number, if any, and 

the applicable component of the 

Department of Justice sponsoring the 

collection: Form Number: DEA Form 

333. Office of Diversion Control, Drug 

Enforcement Administration, United 

States Department of Justice. 

(4) Affected public who will be asked 

or required to respond, as well as a brief 

abstract: Primary: Business or other forprofit. Other: None. Abstract: 

Manufacturers and distributors of 

controlled substances must report 

acquisition/distribution transactions to 

DEA to comply with Federal law and 

international treaty obligations. This 

information helps to ensure a closed 

system of distribution for these 

controlled substances. 

(5) An estimate of the total number of 

respondents and the amount of time 

estimated for an average respondent to 

respond: DEA estimates that 1,334 

persons respond to this collection. DEA 

estimates that it takes 1 hour to 

complete a paper form and 10 minutes 

to complete the form electronically. 

(6) An estimate of the total public 

burden (in hours) associated with the 

collection: DEA estimates this collection 

has a public burden of 1,309 hours 

annually. 

If additional information is required 

contact: Brenda E. Dyer, Department 

Clearance Officer, United States 

Department of Justice, Justice 

Management Division, Policy and 

Planning Staff, Patrick Henry Building, 

Suite 1600, 601 D Street NW., 

Washington, DC 20530.

Dated: December 15, 2004. 

Brenda E. Dyer, 

Department Clearance Officer, Department of 

Justice.

[FR Doc. 04–27839 Filed 12–20–04; 8:45 am] 

BILLING CODE 4410–09–P

NATIONAL AERONAUTICS AND 

SPACE ADMINISTRATION 

[Notice 04–149] 

Aerospace Safety Advisory Panel 

Meeting

AGENCY: National Aeronautics and 

Space Administration.

ACTION: Notice of meeting.

SUMMARY: In accordance with the 

Federal Advisory Committee Act, Public 

Law 92–463, as amended, the National 

Aeronautics and Space Administration 

announces a forthcoming meeting of the 

Aerospace Safety Advisory Panel.

DATES: Thursday, January 27, 2005, 1 

p.m. to 3 p.m. eastern time.

ADDRESS: Florida Space Authority, 

Auditorium, 100 Spaceport Way, Cape 

Canaveral, Florida 32920, (321) 730–

5301.

FOR FURTHER INFORMATION CONTACT: Mr. 

Mark D. Erminger, Aerospace Safety 

Advisory Panel Executive Director, 

Code Q–1, National Aeronautics and 

Space Administration, Washington, DC 

20546, (202) 358–0914.

SUPPLEMENTARY INFORMATION: The 

Aerospace Safety Advisory Panel will 

hold its Quarterly Meeting. This 

discussion is pursuant to carrying out 

its statutory duties for which the Panel 

reviews, identifies, evaluates, and 

advises on those program activities,